Journals / Ankara Medical Journal / 2022 / Cilt: 22 - Sayı: 3

Acupuncture Decreases Attack Frequency and Improves Disability in Patients with Migraine Without Aura: A Randomized Controlled Trial

Pages
370–380
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Acupuncture may be suggested as a complementary treatment option to optimize the clinical management of patients with migraine without aura via decreasing attack frequency and pain severity, also improving disability.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study investigated the effect of acupuncture treatment on attack frequency, pain intensity, and disability in patients with migraine without aura that received prophylaxis treatment.
📊
Key Findings & Data:Materials and Methods: Eighty-four patients with migraine without aura were randomized to the intervention group (IG; n=42) and control group (CG; n=42).
💡
Conclusion & Impact:Conclusion: Acupuncture may be suggested as a complementary treatment option to optimize the clinical management of patients with migraine without aura via decreasing attack frequency and pain severity, also improving disability.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: This study investigated the effect of acupuncture treatment on attack frequency, pain intensity, and disability in patients with migraine without aura that received prophylaxis treatment. Materials and Methods: Eighty-four patients with migraine without aura were randomized to the intervention group (IG; n=42) and control group (CG; n=42). IG received 12 sessions of Acupuncture in addition to prophylaxis treatment. CG received only prophylaxis treatment. The primary outcome measures were monthly attack frequency, duration of attacks and pain severity during attacks. The secondary outcome measure included a change of Migraine Disability Assessment (MIDAS) scores from baseline to endpoints. All participants were followed up for three months. Results: A total of 80 participants completed the study. There were no statistically significant differences between the IG and CG for either socio-demographic features or the outcome measures at baseline. VAS score decreased from 8.8±0.9 to 3.9±1.5 in IG, while it decreased from 8.7±0.8 to 4.4±2.4 in CG (p=0.001). After three months mean monthly attack frequency decreased from 7.2±3.0 to 3.3±2.3 in IG, while it decreased from 6.3±3.3 to 4.4±2.4 in CG (p=0.040). The mean duration of attacks was 12.1± 2.6 hours before intervention; it decreased to 3.1±1.7 hours in IG (p=0.002). There was a significantly higher proportion of participants in IG who had MIDAS Grade 2 compared to those with CG (42.50% versus 2.50%) at the end of the study (p=0.001). Conclusion: Acupuncture may be suggested as a complementary treatment option to optimize the clinical management of patients with migraine without aura via decreasing attack frequency and pain severity, also improving disability.

🔖

Cite This Article

AKINCI, R. R., ÇAYIR, Y., BİLGE, N. (2022). Acupuncture Decreases Attack Frequency and Improves Disability in Patients with Migraine Without Aura: A Randomized Controlled Trial. Ankara Medical Journal, Cilt: 22 - Sayı: 3, 370–380. https://ajindex.com/articles/441698

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Burch RC, Buse DC, Lipton RB. Migraine: Epidemiology, Burden, and Comorbidity. Neurol Clin. 2019;37(4):631-49 (doi:10.1016/j.ncl.2019.06.001)
  2. Group GBDNDC. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877-97 (doi:10.1016/S1474-4422(17)30299-5)
  3. Buse DC, Rupnow MF, Lipton RB. Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc. 2009;84(5):422-35 (doi:10.1016/S0025-6196(11)60561-2)
  4. Gilmore B, Michael M. Treatment of Acute Migraine Headache. Am Fam Physician. 2011;83(3):271-80
  5. Johnston MM, Rapoport AM. Triptans for the management of migraine. Drugs. 2010;70(12):1505-18 (doi:10.2165/11537990-000000000-00000)
  6. Modi S, Lowder DM. Medications for migraine prophylaxis. Am Fam Physician. 2006;73(1):72-8
  7. D'Amico D, Tepper SJ. Prophylaxis of migraine: general principles and patient acceptance. Neuropsychiatr Dis Treat. 2008;4(6):1155-67 (doi:10.2147/ndt.s3497)
  8. Ha H, Gonzalez A. Migraine Headache Prophylaxis. Am Fam Physician. 2019;99(1):17-24
  9. Cayir Y, Ozdemir G, Celik M, et al. Acupuncture decreases matrix metalloproteinase-2 activity in patients with migraine. Acupunct Med. 2014;32(5):376-80 (doi:10.1136/acupmed-2014-010612)
  10. Molsberger A. The role of Acupuncture in the treatment of migraine. CMAJ. 2012;184(4):391-2 (doi:10.1503/cmaj.112032)
  11. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev. 2009(1):CD001218 (doi:10.1002/14651858.CD001218.pub2)
  12. Tfelt-Hansen P, Pascual J, Ramadan N, et al. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Cephalalgia. 2012;32(1):6-38 (doi:10.1177/0333102411417901)
  13. Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire. Headache. 2001;41(9):854-61
  14. Ertaş M, Siva A, Dalkara T, Uzuner N, Dora B, İnan L, et al. Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire. Headache. 2004;44(8):786-93
  15. Wells RE, Bertisch SM, Buettner C, Phillips RS, McCarthy EP. Complementary and alternative medicine use among adults with migraines/severe headaches. Headache. 2011;51(7):1087-